Now, through this interface, HTMs using EQ2’s CMMS service can maintain a more thorough and comprehensive biomedical asset lifecycle management program, with access to manufacturers manuals, IFUs, PM documents, End of Life letters, AEM information and related material.
EQ2 Product Manager Rich Sable was quoted on multiple topics in a comprehensive story on CMMS for Healthcare Facilities that appeared in the July issue of Health Facilities Management magazine.
EQ2 Product Manager Rich Sable talked with TechNation Magazine live at the AAMI 2018 annual event, discussing the EQ2 silver anniversary, specifics of CMMS for healthcare, new product announcements, and the difference of using HEMS for large and small hospitals.
The Company Will be Celebrating the Milestone While Introducing New Feature-Rich Products for its CMMS at the AAMI 2018 Conference and Expo.
Successfully Implementing and Executing an AEM (Alternative Equipment Maintenance) Program Can Seem Daunting but Following a Sound Strategy Can Make all the Difference for an HTM Department
Both Product Manager Rich Sable and Chief Technology Officer Vishal Malhotra are part of the Technation cover story on CMMS: What You Need in the 21st Century – Current Capabilities and Shortfalls
As EQ2 reaches our 25th birthday in 2018, the company is the subject of a feature profile in Technation Magazine!
AAMI’s Biomedical Instrumentation & Technology (BI&T) publication talked with EQ2 CTO Vishal Malhotra for an in-depth discussion on the role of CMMS in healthcare. The article is enlightening for those who hope to better understand the evolution and future of CMMS in healthcare technology management (HTM).
EQ2 is growing and seeking a dedicated professional who is excited to participate in new product development and new modules for existing products.
EQ2 Product Manager Rich Sable chatted with DOTmed HealthCare Business News about topics such as his transition from the hospital side as a Manager of Clinical Engineering, AEM and Regulatory Compliance, and the value of HEMS II.